Synthetic Biology and the Omics Revolution

Size: px
Start display at page:

Download "Synthetic Biology and the Omics Revolution"

Transcription

1 Synthetic Biology and the Omics Revolution by John Dalton of CICM 1

2 Synthetic Biology and the Omics Revolution By John Dalton of CICM Biology and many of its sub-disciplines, in particular those related to molecular biology, have become vibrant and complex areas of research. As molecular medicine and bioengineering continue to develop in their subject knowledge and application, the gap between the ability of scientists to communicate their findings and the ability of the educated non-scientific public to comprehend their relevance broadens. Accordingly, some level of biological literacy is required to grasp many of the issues that frequently fill our media, such as the Human Genome Project, personalised medicine and now, synthetic biology. Equally important is the need for many stakeholders to appreciate their medical, commercial and possible ecological applications. We are witnessing a new bioeconomy emerging that will not only transform how many commercial sectors operate and their efficiency, but also provide complex new challenges to our ethical and legal systems. What is particularly exciting is the potential that genomics and synthetic biology have to tackle complex issues, such as climate change and the growth of antibiotic resistance. The implications for commerce are huge as many processes will be significantly altered through the applications of engineered microbes with novel functions that can improve efficiency, reduce waste and pollution. Medicine will be transformed and many diseases that where previously thought to be incurable may be tackled and suffering and pain reduced or eliminated. In 1977, the scientist Fred Sanger and his team started the field of biology that was to become known as genomics when he successfully managed to sequence the genome of a virus. A genome is a complete set of genes carried by an organism or virus. The term genomics was actually adapted by Professor Hans Winkler1 1 in 1920, but became more familiar with the publicity surrounding the Human Genome Project. Genes are specific segments of DNA that code for a polypeptide (protein) or RNA product. Sanger s work laid the pathway for the sequencing of more complex organisms, leading ultimately to the sequencing of the human genome. The Human Genome Project marked a major development in our understanding of how genes encoded proteins and the link between our genome and many diseases and medical conditions. For those with a basic grounding in science, in particular biology, it is generally understood that our DNA contains genes that code for proteins. How exactly genes coded for the proteins and how these proteins interacted with each other in cells and tissues remained somewhat obscure until the 1990s. All of these new areas of study, based on the genomics revolution, will certainly produce some fascinating and useful insights and applications for humans and other species.. Given that genes give rise to polypeptides or proteins, a second important field of study is called proteomics, which attempts to identify all the proteins present in a cell under various conditions, functions and interactions. The ability to sequence a genome based on the pioneering work of scientists like Sanger back in 1977 led to the Omics revolution, which emerged during the 1990s and is to this date producing more and more exciting areas of research. Some examples of Omics, other than genomics, include: Proteomics - (the study of the proteome): the analysis of all cellular proteins* Transcriptomics - the analysis of all expressed RNA molecules produced in a cell Metabolomics the study of the metabolic networks in a cell or tissue Glycomics (the study of glycomes): the analysis of all the carbohydrate molecules that can be produced by a cell, tissue or organism Toxicogenomics the analysis of the effects of toxic chemicals on genes and gene expression Pharmacogenomics the development of customised medicine based on an individual s specific genetic profile for a specific condition Metagenomics the analysis of genomics collectively from the environment Nutrigenomics the analysis of interactions between diet and genes 1 Winkler, HL (1920). Verbreitung und Ursache der Parthenogenesis im Pflanzen- und Tierreiche. Jena: Verlag Fische 2

3 * Proteomics is of clinical interest because it allows scientists to compare proteins from normal and diseased tissues, which in turn can help identify proteins and specific biomarkers for disease. What is especially noticeable is the pace of change and development that has occurred since the 1990s, catalysed largely by the sequencing of the Human Genome. The Human Genome Project was started in 1990 under the direction of James Watson and was completed in 2003; President Clinton had announced the completion at the White House in June 2000, but this referred only to a draft sequence. What exactly has been achieved by sequencing a complete human genome? Well, in short, something quite remarkable. By sequencing and understanding the order of base sequences that make up human DNA, the international project has transformed our understanding of how genes work, their numbers, their interaction with each other, mutations and many other factors, including our evolutional origins. It has also produced some very significant findings, which surprised some scientists. For example: that we have about 20,000 protein-coding genes, which is far fewer than the numbers predicted (between 80, ,000 genes) less than 2 % of the genome actually codes for proteins the vast majority of the genome is made of noncoding DNA that is essential for the regulation and expression of the coding (exons) regions less than 2 % of the genome actually codes for proteins the vast majority of the genome is made of non-coding DNA that is essential for the regulation and expression of the coding (exons) regions 50% of all human genomes show sequence similarity with other organisms Human genomes are 99.9% similar in sequence diversity from one person to another is due to copy number variations and single-nucleotide polymorphisms 2 For those in medical research, the sequencing of the human genome opened a new, fascinating era of discovery that enable scientists to target genes and help bring under control the damage caused by numerous genetic disorders. As a result of these developments in genomics, biology has increasingly become a more computational science. Known as bioinformatics, computational biology uses biological data to develop algorithms and understand relations within biological systems. The discipline of bioinformatics allows scientists to understand gene structure and sequence as well as protein structure and function. A puzzle for biologists has always been, why are there far more gene products (proteins) transcribed than can be explained by the 20,000 protein-encoding genes identified thus far? Today scientists are only beginning to unravel the complexities of how proteins are produced and how genes are regulated. What has become clear is that proteins have complex interactions with each other: the proteome is far more complex than the genome. Bioinformatics and molecular modelling are necessary to understand the relationship between genomics, proteomics and metabolomics and how these interactions relate to physiology and the development and treatment of specific diseases. 2 A single-nucleotide polymorphism is any position in the genome where there is a difference in a single nucleotide between two unrelated members of the same species 3

4 One of the most interesting developments to arise from the growth in research about the basis of disease is our understanding of how microbes interact with each other and their capacity to cause disease. For years it was thought that many microbes were independent functioning organisms, yet research based on what is now called the Human Microbiome Project 3 suggests that microbes are far more commensal and mutualistic than previously considered. The Human Microbiome Project has certain specific objectives, including determining whether changes in the human microbiome can be correlated with specific diseases and health, and if individuals share a common microbiome. The project relies heavily on the sequencing techniques of genomics to explore keys areas of the microbiome: oral, nasal, skin, conjunctival, urogenital and gastrointestinal. What are the benefits of Genomics? Personalised Medicine One of the principal benefits that will emerge from genomics is personalised medicine. This medical model seeks to customise healthcare by targeting drugs and therapies to treat not just patients within a population, but more importantly, individuals. The ability to determine an individual s unique molecular characteristics and use this information to more accurately predict susceptibility to disease, treat outcomes, and reduce the likelihood of adverse effects of drugs are all potential benefits from what is termed personalized medicine. In essence, personalised medicine is a model that seeks to customise healthcare by removing the traditional one size fits all approach. If you are ill with a condition then it very likely that someone else with the same condition will receive the same treatment, albeit a different dosage. Using each person s unique genetic basis, personalised medicine hopes to provide more targeted and effective treatments. Currently, genetic analysis of patients has already improved targeted therapies for blood clots, colorectal cancer and breast cancer. The opportunities for further more accurate and targeted therapies are significant once the price and availability of sequencing improves and our understanding of biomarkers develops. For it to become clinically effective, personalised medicine requires human genomes to be sequenced at relatively low cost, and to identify gene polymorphisms (genetic changes that are responsible for human disease). The race is currently on to sequence a human genome for less than $1000 in order to stimulate technological innovation to bring down the cost of sequencing, making it accessible and economically viable. To understand the genetic basis of many complex diseases, biologists are now using rapid genotyping technologies that create haplotype maps, which in turn, are used to identify single nucleotide polymorphisms (SNPs) and copy number variants (CNVs) that are linked to genes involved in disease. The key benefits of personalised medicine can be summarised thus: Develop more effective and targeted drug therapies (pharmacogenomics and toxicogenomics) * Customise disease prevention strategies Reduce or eliminate costly drug trials Help in the prediction of diseases and disease detection *By understanding the unique sequences in our DNA and the genetic variation that they imply, scientists will be more able to develop drugs that are specific to biomarkers. Personalised medicine may also reduce the side effects of drugs and other toxins in the body. Many people suffer severe sideeffects from certain drugs, while others within the population suffer limited or no side-effects. 3 A microbiome is a totality of microbes, their genomes and environmental interactions in a specific environment 4

5 Personalised medicine represents a real paradigm shift in medicine by focusing on prevention rather than reaction. In particular, personalised medicine is well suited to tackle complex diseases such as cancer, heart disease, neurodegenerative conditions and diabetes, more than, for examples, genetic diseases such as cystic fibrosis, which come under the umbrella of genetic medicine. A disease such as cancer has numerous gene and environmental interactions and is therefore best studied at the genome level. The Omics Revolution is not just about Molecular Medicine Metagenomics or environmental genomics is a fascinating field of study that involves analysing DNA samples from environmental samples without isolating intact organisms. This discipline was heavily influenced by J. Craig Venter and his expedition called Sorcerer II Global Ocean, in which Venter and his researchers sampled oceans in various parts of the world during The results produced numerous new microbial sequences not previously known to science whose protein use and function is still to be determined. For example, from the expedition, one kilogram of marine sediment contained a million different viruses, most of them new to science. The sequencing of bacterial and viral genomes has numerous potential benefits. Sequencing of organisms, such as Streptomyces coelicolor (source of genes for many natural antibiotics), E coli (strain 0157:H7 (pathogenic bacterium) Mycobacterium tuberculosis (causes tuberculosis) and Rickettsia prowazekii (causes typhus) provides useful insights into how these organisms may exchange genes with other microbes and cause superbugs. Indeed, the growth of antibiotic resistance has become a major threat to public health, with the possibility of making many current routine operations life threatening within 20 years of something is not done to combat the resistance. In March 2013, the government s Chief Medical Officer for England went as far to state that the threat posed by antibiotic resistance should be ranked alongside terrorism as a risk to the UK security. In addition to functional genomics, there is comparative genomics, which compares genomes of different species. Comparative genomics is important in the understanding of evolution and the function of multi-gene families as well as the mechanisms of action of many microbes and how their genetic systems bring about diseases. Currently, the following other genomes, other than Man s have been sequenced: dog Canis familiaris; chimpanzee Pan troglodytes; Rhesus macaque monkey Macaca mulatta, and the sea urchin, Strongylocentrotus purpuratus. Synthetic Biology Synthetic biology is the result of the confluence of a number of different scientific disciplines: molecular biology, physical science and engineering. The term synthetic biology means the re-engineering of biological components to provide new design functions. In essence, it is the engineering of biology and the synthesis of complex, biologically-based systems, which display functions that may not exist in nature. n 1995 J. Craig Venter and his team determined the genomic sequence of a free-living cellular organism, the bacterium, Haemophilus influenza, which can cause meningitis. After the completion of the Human Genome Project in 2003, Venter announced in 2007 the completion of a single human s genome (his own). Then in May 2010, Venter announced to the world that his team had successfully produced the first man-made bacterium Mycoplasma mycoides JCVIsyn.1.0. This was according to Venter the first synthetic organism ever. The cell became known as Synthia and its genome had been compiled inside a computer. 5

6 Synthia was clear evidence that it was possible to artificially construct a genome and, furthermore, possible to place this synthetic genome inside a recipient cell, so that the cell functions and reproduces like any other bacterium. Responsibly, Vender s team ensured that Synthia was incapable of infection and could only be grown in a highly specific form of lab media. The ultimate question for most people is, did Venter and his team really create life? The best answer is that he re-created a life form synthetically using a computer-generated genome, which was placed inside an existing recipient cell. Whatever way one looks at the situation, it certainly was unique and such a life form had not previously existed. The experiment relied upon other pre-existing life forms to become a reality, for example the host cell. What is clear is that the experiment will certainly go down in science history as the start of a new revolution in biological sciences, making synthetic biology a multidisciplinary science. Synthetic biology can be distinguished from systems biology 4 in a number of ways. First, systems biology attempts to quantify biological systems by incorporating data from genomics, transcriptomics, proteomics and various other sub disciplines, plus engineering applications. In synthetic biology the principal focus is on the rationale engineering of organisms to produce useful, novel functions. What are the Implications of Synthetic Biology? Although it is early days, there is no doubt that synthetic biology will go on to produce some very useful benefits to Mankind and other organisms. In particular, at this stage it is suggested that synthetic biology will have an important role to play in: Disease prevention, drug design, and clinical therapies Bio-energy and synthetic fuels Environmental protection and remediation Agriculture and food production; in particular novel agrochemicals Consumer and chemical production; e.g. synthetic rubber or less toxic biodispersants Development of highly adaptive antibiotics Development of highly effective biosensors Using the techniques of synthetic biology the chemical industry will witness a fundamental transformation from oil-based chemicals towards fuels based on biomass, owing to developments in synthetic biology. Synthetic biology also promises vaccine development and better understanding of viruses, such as the Bluetongue virus (BTV), which has the capacity to inflict serious damage on livestock, in particular sheep, globally. Currently, synthetic biology is not a reality and is a very nascent discipline. But just like so many other technological or other biological revolutions, synthetic biology clearly has sound scientific logic behind it and it is merely a matter of time and innovation for it to become a reality and its products and actions to transform our lives. Fears over Synthetic Biology Many of the fears and issues raised over synthetic biology are exaggerated, in particular the threat from biological terrorism. Advocates for synthetic biology are quick to point out that any attempt to manipulate the genome of a microbe to create a weapon of terror would take much time, effort, scientific know-how and investment of resources and finances. 4 Systems biology is a discipline that seeks to determine how complex biological systems function by integrating experimentally derived information through mathematical and computing solutions 6

7 Weaponising engineered life forms has been a fear since the advancement of genetic engineering and the issue of GM microbes stockpiles developed during the Cold War. A further issue that has been consistently raised by many is the availability of genome sequences online, such as the smallpox genome. Despite all the rhetoric, it is still difficult to engineer life and create or manipulate a microbe for dissemination for the purposes of terrorism. That said, it is also fair to be cautious. As technologies improve this will enhance the ease with which synthetic biology can be conducted by gifted amateurs and PhD terrorists (a termed coined by John Dalton). There is a case for monitoring developments outside of regulated scientific research. A well-resourced and funded laboratory, possibly under the guidance or direction of an anti-western power or group, might conceivably be able to engineer a deadly virus or bacterium for terrorists purposes. Many important questions have arisen regarding genomics and synthetic biology. Should pathogenic viral and bacterial genomes be available online for all to see and access? Should researchers make available to the general public research material that shows how they made a strain? In 2002 scientists at Stony Brook University in the US recreated a polio virus based on its genetic sequence. Scientists have also recreated the highly pathogenic flu virus that killed millions in 1918 in order to gain insight into what part of its genetic makeup made it so pathogenic. One of the dangers is that synthetic biology might become de-skilled and made more open with time and this has obvious bio-security implications. Fears over so-called garage biologists is growing although little evidence to-date suggests that they will become a significant threat, but as with any new technology it makes perfect sense to keep a close eye on developments and regulate and restrict its use and applications so as to prevent the release of dangerous synthetic genomes into nature. This is likely to happen at some stage, either through an accident or via a deliberate release. Although the threat of misuse of synthetic biology to the public or from determined terrorists may not be that great, what is clear is that bioterrorism, if it did occur, would have devastating consequences as a weapon of terror. If, for whatever reason, a biological weapon was released inside an airport, at a large sporting event or in a shopping mall, how well prepared are our governments and authorities to deal with the matter? Furthermore, in relation to a bioterrorism attack, however unlikely, how many of our health workers have been vaccinated against pathogenic organisms? Complexity and Business implications Investors and venture capitalists are showing increased interest in the potential applications of the genomics revolution and synthetic biology. Issues relating to intellectual property, in particular patenting organisms, as well as ethical arguments, are just the tip of a very large iceberg. As bioengineering becomes ever more specialised, business people who do not have a grounding in science, will have to work harder to keep up-to-date with developments and potential commercial applications. The gap between science and business in many ways grows wider every day as the pace of discovery and hyper-specialisation of scientific knowledge increases. It is therefore vital that complex scientific advances are broken down and communicated to non-scientists in a way that allows the business community to absorb and assimilate developments, their significance and potential, without being bogged down in scientific terminology or convoluted detail. In an emerging bioeconomy, a confluence of disciplines is inevitable, which in turn must be reflected through our education and training systems, arguing for a more multidisciplinary approach. 7

8 A typical MBA student may be able to read a balance sheet and understand the concept of applied strategy in a commercial context, but just learning about pure business may lead to serious deficiencies of knowledge and application in a rapidly emerging bioeconomy. Will this result in a change in how business students are taught or lead to the demise of the current MBA dominance in education? Will it result in more postgraduate courses that are multidisciplinary in their approach, bridging the artificial gap between science and business? The trend towards multidiscipline postgraduate courses has already started, reflecting this very need, but the number and diversity of courses is low. Investors and those who are prepared to take risks in new ventures need to understand what exactly it is they are investing in and the associated risks. In some ways disruptive technology developments are often easier to explain to investors than significant developments in biology or engineering. This is the essence of the problem modern biology and genetics when combined with engineering becomes incredibly complex and is difficult to easily comprehend. This in turn may result in journalists and bloggers miscommunicating outcomes and generating unnecessary fears. Risk management relies upon decision-makers taking risks, but in an environment where the risk exposure is not too great and where the risks by and large are understood and manageable. In the case of genomics and its related fields of synthetic biology, the risks become ever more complex and interdependent, making it harder for business executives and investors to take a view. Many business executives are informed by the general and business media: Financial Times, Bloomberg, The Economist, or investor bulletins or trade journals. All of these are written by business and financial journalists who, despite being extremely able in their own right, may not adequately convey risks in context or may report uncorroborated claims made by campaigning NGOs or activists who may have motives that are against the use of the technology. If the nanotechnology revolution is a guide, then genomics and synthetic biology will not have such a tough time but when one starts to play with nature, far more irrational fears surface, fuelled by well meaning, but often misguided or ill-informed activists. by John Dalton 8

21.5 The "Omics" Revolution Has Created a New Era of Biological Research

21.5 The Omics Revolution Has Created a New Era of Biological Research 21.5 The "Omics" Revolution Has Created a New Era of Biological Research 1 Section 21.5 Areas of biological research having an "omics" connection are continually developing These include proteomics, metabolomics,

More information

Up Close and Personal

Up Close and Personal Special Report Up Close and With Personal advances in genetics, a new type of medicine has emerged: one that s tailored just for you and your DNA. Could it transform the paradigm of how we treat and prevent

More information

Frumkin, 2e Part 1: Methods and Paradigms. Chapter 6: Genetics and Environmental Health

Frumkin, 2e Part 1: Methods and Paradigms. Chapter 6: Genetics and Environmental Health Frumkin, 2e Part 1: Methods and Paradigms Chapter 6: Genetics and Environmental Health Genetics Genetics, the study of individual genes, has expanded to include genomics, which is the study of all the

More information

- OMICS IN PERSONALISED MEDICINE

- OMICS IN PERSONALISED MEDICINE SUMMARY REPORT - OMICS IN PERSONALISED MEDICINE Workshop to explore the role of -omics in the development of personalised medicine European Commission, DG Research - Brussels, 29-30 April 2010 Page 2 Summary

More information

Lesson Overview. Studying the Human Genome. Lesson Overview Studying the Human Genome

Lesson Overview. Studying the Human Genome. Lesson Overview Studying the Human Genome Lesson Overview 14.3 Studying the Human Genome THINK ABOUT IT Just a few decades ago, computers were gigantic machines found only in laboratories and universities. Today, many of us carry small, powerful

More information

Introduction to Bioinformatics

Introduction to Bioinformatics Introduction to Bioinformatics Alla L Lapidus, Ph.D. SPbSU St. Petersburg Term Bioinformatics Term Bioinformatics was invented by Paulien Hogeweg (Полина Хогевег) and Ben Hesper in 1970 as "the study of

More information

Challenges for the Governance of Synthetic Biology and Implications for UN Security Council resolution 1540 (2004)

Challenges for the Governance of Synthetic Biology and Implications for UN Security Council resolution 1540 (2004) Challenges for the Governance of Synthetic Biology and Implications for UN Security Council resolution 1540 (2004) Nancy Connell, PhD Johns Hopkins Center for Health Security US-NAS Board on Life Sciences

More information

Chapter 10 Microbial Genetics: New Genes for Old Germs

Chapter 10 Microbial Genetics: New Genes for Old Germs Chapter 10 Microbial Genetics: New Genes for Old Germs Objectives: After reading Chapter Ten, you should understand The structure and complexity of the bacterial chromosome and the significance of plasmids.

More information

Biodefense implications of Synthetic Biology & Emerging Technologies

Biodefense implications of Synthetic Biology & Emerging Technologies Biodefense implications of Synthetic Biology & Emerging Technologies Diane DiEuliis, Ph.D. National Defense University IEEE May 17, 2018 1 Hope for innovative solutions to global problems Health: antimicrobial

More information

At the end of this lesson you should be able to

At the end of this lesson you should be able to At the end of this lesson you should be able to 1. Define Genetic Engineering 2. Outline the process of genetic engineering involving some or all of the following: isolation, cutting, transformation, introduction

More information

Microbial Metabolism Systems Microbiology

Microbial Metabolism Systems Microbiology 1 Microbial Metabolism Systems Microbiology Ching-Tsan Huang ( 黃慶璨 ) Office: Agronomy Hall, Room 111 Tel: (02) 33664454 E-mail: cthuang@ntu.edu.tw MIT OCW Systems Microbiology aims to integrate basic biological

More information

Genetics Lecture 21 Recombinant DNA

Genetics Lecture 21 Recombinant DNA Genetics Lecture 21 Recombinant DNA Recombinant DNA In 1971, a paper published by Kathleen Danna and Daniel Nathans marked the beginning of the recombinant DNA era. The paper described the isolation of

More information

Exome Sequencing Exome sequencing is a technique that is used to examine all of the protein-coding regions of the genome.

Exome Sequencing Exome sequencing is a technique that is used to examine all of the protein-coding regions of the genome. Glossary of Terms Genetics is a term that refers to the study of genes and their role in inheritance the way certain traits are passed down from one generation to another. Genomics is the study of all

More information

Studying the Human Genome. Lesson Overview. Lesson Overview Studying the Human Genome

Studying the Human Genome. Lesson Overview. Lesson Overview Studying the Human Genome Lesson Overview 14.3 Studying the Human Genome THINK ABOUT IT Just a few decades ago, computers were gigantic machines found only in laboratories and universities. Today, many of us carry small, powerful

More information

Biotechnology: Genomics: field that compares the entire DNA content of different organisms

Biotechnology: Genomics: field that compares the entire DNA content of different organisms Biotechnology: New Terms Today: Genome Genetic engineering, transgenic organisms, GM food, Reproductive and therapeutic cloning Stem cells, plouripotent, totipotent Gene therapy Genomics: field that compares

More information

Growing Together: How Viruses Have Shaped Human Evolution. Shirlee Wohl Katherine Wu

Growing Together: How Viruses Have Shaped Human Evolution. Shirlee Wohl Katherine Wu Growing Together: How Viruses Have Shaped Human Evolution Shirlee Wohl Katherine Wu What comes to your mind when you hear the word virus? flu public health cold vaccine infection disease cough biology

More information

Our website:

Our website: Biomedical Informatics Summer Internship Program (BMI SIP) The Department of Biomedical Informatics hosts an annual internship program each summer which provides high school, undergraduate, and graduate

More information

ETHICAL, LEGAL AND SOCIAL ISSUES IN DRUG DEVELOPMENT AND PHARMACOGENOMICS: Report on a Qualitative Study of the Perspectives of Canadian Stakeholders

ETHICAL, LEGAL AND SOCIAL ISSUES IN DRUG DEVELOPMENT AND PHARMACOGENOMICS: Report on a Qualitative Study of the Perspectives of Canadian Stakeholders ETHICAL, LEGAL AND SOCIAL ISSUES IN DRUG DEVELOPMENT AND PHARMACOGENOMICS: Report on a Qualitative Study of the Perspectives of Canadian Stakeholders SHANNON GIBSON University of Toronto Faculty of Law

More information

University of Athens - Medical School. pmedgr. The Greek Research Infrastructure for Personalized Medicine

University of Athens - Medical School. pmedgr. The Greek Research Infrastructure for Personalized Medicine University of Athens - Medical School pmedgr The Greek Research Infrastructure for Personalized Medicine - George Kollias - Professor of Experimental Physiology, Medical School, University of Athens President

More information

CHAPTER 21. Genetic engineering. What is Genetic Engineering? How is genetic engineering used? What are plasmids? DNA Technology Genomics.

CHAPTER 21. Genetic engineering. What is Genetic Engineering? How is genetic engineering used? What are plasmids? DNA Technology Genomics. CHAPTER 21 DNA Technology Genomics What is Genetic Engineering? Genetic engineering Moving genes from one organism to another Genes can be taken from one organism (plant, animal, virus, or bacteria) and

More information

Following text taken from Suresh Kumar. Bioinformatics Web - Comprehensive educational resource on Bioinformatics. 6th May.2005

Following text taken from Suresh Kumar. Bioinformatics Web - Comprehensive educational resource on Bioinformatics. 6th May.2005 Bioinformatics is the recording, annotation, storage, analysis, and searching/retrieval of nucleic acid sequence (genes and RNAs), protein sequence and structural information. This includes databases of

More information

Chapter 15 Gene Technologies and Human Applications

Chapter 15 Gene Technologies and Human Applications Chapter Outline Chapter 15 Gene Technologies and Human Applications Section 1: The Human Genome KEY IDEAS > Why is the Human Genome Project so important? > How do genomics and gene technologies affect

More information

Just the Facts: A Basic Introduction to the Science Underlying NCBI Resources

Just the Facts: A Basic Introduction to the Science Underlying NCBI Resources National Center for Biotechnology Information About NCBI NCBI at a Glance A Science Primer Human Genome Resources Model Organisms Guide Outreach and Education Databases and Tools News About NCBI Site Map

More information

Microbial Biotechnology agustin krisna wardani

Microbial Biotechnology agustin krisna wardani Microbial Biotechnology agustin krisna wardani 1. The Structure of Microbes Microbes (microorganisms) are tiny organisms that are too small to be seen individually by the naked eye and must be viewed with

More information

Name: Score: / Quiz 7 on Pharmaceutical Biotechnology. Part 1. A. organ transplantation. B. xenotransplatation. C. animal cloning. D.

Name: Score: / Quiz 7 on Pharmaceutical Biotechnology. Part 1. A. organ transplantation. B. xenotransplatation. C. animal cloning. D. Name: Score: / Quiz 7 on Pharmaceutical Biotechnology Part 1 Immune cells have been genetically modified to treat cancer. Stem cells, as well as other cells in tissues and organs in the human body, have

More information

A Biomedical Research and Biotechnology Center to Promote the Growth of World-Class Biotech Industry in Southern Italy

A Biomedical Research and Biotechnology Center to Promote the Growth of World-Class Biotech Industry in Southern Italy Repair, Replacement, Regeneration & Reprogramming The Official Journal of The Cure Alliance A Biomedical Research and Biotechnology Center to Promote the Growth of World-Class Biotech Industry in Southern

More information

Pioneering Clinical Omics

Pioneering Clinical Omics Pioneering Clinical Omics Clinical Genomics Strand NGS An analysis tool for data generated by cutting-edge Next Generation Sequencing(NGS) instruments. Strand NGS enables read alignment and analysis of

More information

Unit 2: Metabolism and Survival Sub-Topic (2.7) Genetic Control of Metabolism (2.8) Ethical considerations in the use of microorganisms

Unit 2: Metabolism and Survival Sub-Topic (2.7) Genetic Control of Metabolism (2.8) Ethical considerations in the use of microorganisms Unit 2: Metabolism and Survival Sub-Topic (2.7) Genetic Control of Metabolism (2.8) Ethical considerations in the use of microorganisms Duncanrig Secondary JHM&MHC 2015 Page 1 of 18 On completion of this

More information

Centre for Digital Life Norway (DLN) - Interdisciplinary research, education and innovation

Centre for Digital Life Norway (DLN) - Interdisciplinary research, education and innovation Centre for Digital Life Norway (DLN) - Interdisciplinary research, education and innovation By Trygve Brautaset Centre leader Biotechnology Biotechnology is a science in rapid development! Interdisciplinarity

More information

Personalized. Health in Canada

Personalized. Health in Canada Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute

More information

WHAT IS BIOCHEMISTRY

WHAT IS BIOCHEMISTRY WHAT IS BIOCHEMISTRY Each part of every living being is biochemically connected. Biochemistry is at the heart of life science. It is a fascinating, diverse and sprawling discipline; which makes it near

More information

Introduction to Bioinformatics

Introduction to Bioinformatics Introduction to Bioinformatics If the 19 th century was the century of chemistry and 20 th century was the century of physic, the 21 st century promises to be the century of biology...professor Dr. Satoru

More information

CS 6824: New Directions in Computational Systems Biology

CS 6824: New Directions in Computational Systems Biology CS 6824: New Directions in Computational Systems Biology T. M. Murali January 19, 2011 Course Structure Discuss state-of-the-art research papers. Course Structure Lectures Discuss state-of-the-art research

More information

Biotech Patents in Europe

Biotech Patents in Europe Biotech Patents in Europe Introduction This circular relates to biotech patent practice in Europe. It is based on our experience of drafting and prosecuting biotech applications. The circular is written

More information

1 Exclusive Rights in Life: Biotechnology, Genetic Manipulation, and Intellectual Property Rights

1 Exclusive Rights in Life: Biotechnology, Genetic Manipulation, and Intellectual Property Rights 1 Exclusive Rights in Life: Biotechnology, Genetic Manipulation, and Intellectual Property Rights E.R. GOLD 1.1 Introduction Attending any biotechnology conference will confirm it. Amid all the discoveries

More information

University of Delaware Department of Environmental Health & Safety Recombinant DNA Registration

University of Delaware Department of Environmental Health & Safety Recombinant DNA Registration Registration #: University of Delaware Department of Environmental Health & Safety Recombinant DNA Registration Directions: Please complete this form to register recombinant DNA research with the University

More information

E&T objectives in evolving pharma business models. Magda Chlebus Director Science Policy Brussels, 2 March 2015

E&T objectives in evolving pharma business models. Magda Chlebus Director Science Policy Brussels, 2 March 2015 E&T objectives in evolving pharma business models Magda Chlebus Director Science Policy Brussels, 2 March 2015 Education adapted to demand? Declining number of students choosing science Education still

More information

2017 Amplyus, all rights reserved

2017 Amplyus, all rights reserved The Human Genome Project What it is: The initiative that sequenced the entire human genome The Human Genome Project (HGP) is widely recognized as a tremendous success of government initiative and international

More information

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 Pharmacogenetics: A SNPshot of the Future Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 1 I. What is pharmacogenetics? It is the study of how genetic variation affects drug response

More information

NATIONAL SCIENCE AND TECHNOLOGY COUNCIL. National Research and Development Strategy for Microbial Forensics

NATIONAL SCIENCE AND TECHNOLOGY COUNCIL. National Research and Development Strategy for Microbial Forensics NATIONAL SCIENCE AND TECHNOLOGY COUNCIL National Research and Development Strategy for Microbial Forensics National Strategy to Support Research in Microbial Forensics Attribution Investigations and National

More information

-Is the process of manipulating genes and genomes

-Is the process of manipulating genes and genomes Genetic Engineering -Is the process of manipulating genes and genomes Biotechnology -Is the process of manipulating organisms or their components for the purpose of making useful products Restriction Enzymes

More information

Unit 8.3: Biotechnology

Unit 8.3: Biotechnology Unit 8.3: Biotechnology Lesson Objectives Describe gene cloning and the polymerase chain reaction. Explain how DNA technology is applied in medicine and agriculture. Identify some of the ethical, legal,

More information

Genomics. Genomics. Understanding the human genome. The human genome. Genomics = study of an organism s entire genome or entire DNA sequence

Genomics. Genomics. Understanding the human genome. The human genome. Genomics = study of an organism s entire genome or entire DNA sequence Genomics Genomics Genomics = study of an organism s entire genome or entire DNA sequence billion bases % of DNA shared Humans 3.2 99.5% Chimpanzee 2.8 98.5% Mouse 2.5 80% Chicken 1.0 So what s a genome?

More information

Course Agenda. Day One

Course Agenda. Day One Course Agenda BioImmersion: Biotech for the Non-Scientist A three-day, in-depth course that provides the background required for understanding today s fast-paced biotech marketplace. Beginning with an

More information

Personalised Medicine Regulatory Issues

Personalised Medicine Regulatory Issues Personalised Medicine Regulatory Issues INFRAFRONTIER / IMPC Stakeholder Meeting Presented by Marisa Papaluca on 14 November 2017 Senior Scientific Advisor, Scientific Committees Regulatory Science Strategy

More information

Duncanrig Secondary School

Duncanrig Secondary School National 4 Biology Unit 1Topic 3: Therapeutic Uses of Cells, Duncanrig Secondary School Duncanrig Secondary School National 4 Biology Unit 1 Topic 3: Therapeutic Uses of Cells Pupils Activity Booklet National

More information

Biotechnology, Synthetic Biology, and Genetic Circuit Design Module Lesson Plan. 1 day. 1 P age

Biotechnology, Synthetic Biology, and Genetic Circuit Design Module Lesson Plan. 1 day. 1 P age 1 P age Biotechnology, Synthetic Biology, and Genetic Circuit Design Module Lesson Plan 1 day 2 P age Introduction In this single module students will build upon their previous knowledge of basic molecular

More information

Chapter 11: Applications of Biotechnology

Chapter 11: Applications of Biotechnology Chapter 11: Applications of Biotechnology Lecture Outline Enger, E. D., Ross, F. C., & Bailey, D. B. (2012). Concepts in biology (14th ed.). New York: McGraw- Hill. 11-1 Why Biotechnology Works 11-2 Biotechnology

More information

GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS

GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS 1. Introduction 1.1 This document provides guidance notes for the assessment of academic qualifications that have not been formally accredited

More information

Basic Concepts and History of Genetic Engineering. Mitesh Shrestha

Basic Concepts and History of Genetic Engineering. Mitesh Shrestha Basic Concepts and History of Genetic Engineering Mitesh Shrestha Genetic Engineering AKA gene manipulation, gene cloning, recombinant DNA technology, genetic modification, and the new genetics. A technique

More information

Pharmacogenetics of Drug-Induced Side Effects

Pharmacogenetics of Drug-Induced Side Effects Pharmacogenetics of Drug-Induced Side Effects Hui - Ching Huang Department of Pharmacy, Yuli Hospital DOH Department of Pharmacology, Tzu Chi University April 20, 2013 Brief history of HGP 1953: DNA

More information

BIOLOGICAL BASIS OF PUBLIC HEALTH BMS505, Fall 2012 Syllabus

BIOLOGICAL BASIS OF PUBLIC HEALTH BMS505, Fall 2012 Syllabus Course Director: BIOLOGICAL BASIS OF PUBLIC HEALTH BMS505, Fall 2012 Syllabus Location and meeting times Mo/We 10:30am 11:50am, George Auditorium Martin Tenniswood, PhD Department of Biomedical Sciences

More information

What is the Difference between a Human and a Chimp? T. M. Murali

What is the Difference between a Human and a Chimp? T. M. Murali What is the Difference between a Human and a Chimp? T. M. Murali murali@cs.vt.edu http://bioinformatics.cs.vt.edu/ murali Introduction to Computational Biology and Bioinformatics (CS 3824) March 25 and

More information

Strategy for Biological Risk & Security

Strategy for Biological Risk & Security Strategy for Biological Risk & Security Drew Endy MIT Biology & Biological Engineering http://mit.edu/endy/ 1 Document Background: The material in this document is taken from the DARPA ISAT Synthetic Biology

More information

Virus- infectious particle consisting of nucleic acid packaged in a protein coat.

Virus- infectious particle consisting of nucleic acid packaged in a protein coat. Chapter 19 Virus- infectious particle consisting of nucleic acid packaged in a protein coat. Most scientists consider viruses non-living because they cannot reproduce or carry out metabolic activities

More information

Course Descriptions. BIOL: Biology. MICB: Microbiology. [1]

Course Descriptions. BIOL: Biology. MICB: Microbiology.  [1] Course Descriptions BIOL: Biology http://www.calendar.ubc.ca/vancouver/courses.cfm?code=biol [1] BIOL 112 (3) Biology of the Cell The principles of cellular and molecular biology using bacterial and eukaryotic

More information

CHAPTER 2A HOW DO YOU BEGIN TO CLONE A GENE? CHAPTER 2A STUDENT GUIDE 2013 Amgen Foundation. All rights reserved.

CHAPTER 2A HOW DO YOU BEGIN TO CLONE A GENE? CHAPTER 2A STUDENT GUIDE 2013 Amgen Foundation. All rights reserved. CHAPTER 2A HOW DO YOU BEGIN TO CLONE A GENE? 35 INTRODUCTION In the Program Introduction, you learned that the increase in diabetes in the United States has resulted in a great demand for its treatment,

More information

INTRODUCTION TO GENETIC EPIDEMIOLOGY (EPID0754) Prof. Dr. Dr. K. Van Steen

INTRODUCTION TO GENETIC EPIDEMIOLOGY (EPID0754) Prof. Dr. Dr. K. Van Steen INTRODUCTION TO GENETIC EPIDEMIOLOGY (EPID0754) Prof. Dr. Dr. K. Van Steen CHAPTER 1: SETTING THE PACE 1 Course Responsible Contact details 2 Administrative Issues Course details and examination methods

More information

17th EHFG Electing Health The Europe We Want!

17th EHFG Electing Health The Europe We Want! 01 03 October 2014 17th EHFG Electing Health The Europe We Want! For more information about the final programme, speakers or the EHFG conference please contact us directly! Follow us on our social media

More information

Testimony of the. Federation of American Societies for Experimental Biology. Prepared for the. House Committee on Appropriations

Testimony of the. Federation of American Societies for Experimental Biology. Prepared for the. House Committee on Appropriations Contact: Benjamin H. Krinsky, PhD Senior Legislative Affairs Officer Federation of American Societies for Experimental Biology (FASEB) bkrinsky@faseb.org Testimony of the Federation of American Societies

More information

+ + + MALARIA HIV/AIDS TUBERCULOSIS LEISHMANIASIS CHAGAS DISEASE DENGUE EBOLA ZIKA

+ + + MALARIA HIV/AIDS TUBERCULOSIS LEISHMANIASIS CHAGAS DISEASE DENGUE EBOLA ZIKA At the Center for Infectious Disease Research, we use systems biology approaches and cutting-edge technologies to accelerate the development of life-saving drugs, diagnostics and treatments for the world

More information

PLTW Biomedical Science Medical Interventions Course Outline

PLTW Biomedical Science Medical Interventions Course Outline Follow the fictitious Smith family as you learn about the prevention, diagnosis, and treatment of disease. Play the role of biomedical professionals to analyze case information and diagnose and treat your

More information

Viral Genomes. Genomes may consist of: 1. Double Stranded DNA 2. Double Stranded RNA 3. Single-stranded RNA 4. Single-stranded DNA

Viral Genomes. Genomes may consist of: 1. Double Stranded DNA 2. Double Stranded RNA 3. Single-stranded RNA 4. Single-stranded DNA Chapter 19 Viral Genomes Genomes may consist of: 1. Double Stranded DNA 2. Double Stranded RNA 3. Single-stranded RNA 4. Single-stranded DNA Genome is usually organized as a single linear or circular molecule

More information

THE ERA OF INDIVIDUAL GENOMES. Sandra Viz Lasheras Advanced Genetics ( )

THE ERA OF INDIVIDUAL GENOMES. Sandra Viz Lasheras Advanced Genetics ( ) THE ERA OF INDIVIDUAL GENOMES Sandra Viz Lasheras Advanced Genetics (2017-2018) CONTENTS 1. INTRODUCTION - The genomic era - Sequencing techniques 2. PROJECTS - 1000 genomes project - Individual genome

More information

Growing Needs for Practical Molecular Diagnostics: Indonesia s Preparedness for Current Trend

Growing Needs for Practical Molecular Diagnostics: Indonesia s Preparedness for Current Trend Growing Needs for Practical Molecular Diagnostics: Indonesia s Preparedness for Current Trend Dr. dr. Francisca Srioetami Tanoerahardjo, SpPK., MSi Essential Practical Molecular Diagnostics Seminar Hotel

More information

Goals of pharmacogenomics

Goals of pharmacogenomics Goals of pharmacogenomics Use drugs better and use better drugs! People inherit/exhibit differences in drug: Absorption Metabolism and degradation of the drug Transport of drug to the target molecule Excretion

More information

BIOTECHNOLOGY SYSTEMS CAREER PATHWAY

BIOTECHNOLOGY SYSTEMS CAREER PATHWAY Plant Systems Te Power, r Structural and T chnical Systems Natural Resource Car Systems eer Pathway A F N R A F N R Agribusiness Systems C A R E E R C O N T E N T C L U S T E R Career Ready Practices Content

More information

Genes & Medicine: How DNA is Improving Your Health

Genes & Medicine: How DNA is Improving Your Health Genes & Medicine: How DNA is Improving Your Health U3A Mountford, June 2004 Dr Martin Kennedy Department of Pathology Christchurch School of Medicine & Health Sciences University of Otago What this talk

More information

Forecast diagnostics for antimicrobial resistance (AMR)

Forecast diagnostics for antimicrobial resistance (AMR) Forecast diagnostics for antimicrobial resistance (AMR) Authors: Ann Van den Bruel, Philip Turner NIHR Diagnostic Evidence Cooperative Oxford, University of Oxford Context When asked to make forecasts

More information

First Place Essay. Katie P.

First Place Essay. Katie P. First Place Essay Katie P. Eighth Grade West Reading, PA 19611 Bioscience research is seeking information by exploring life's processes and diseases. It has helped many scientists understand how the body

More information

Lecture Series 10 The Genetics of Viruses and Prokaryotes

Lecture Series 10 The Genetics of Viruses and Prokaryotes Lecture Series 10 The Genetics of Viruses and Prokaryotes The Genetics of Viruses and Prokaryotes A. Using Prokaryotes and Viruses for Genetic Experiments B. Viruses: Reproduction and Recombination C.

More information

Biotechnology Chapter 20

Biotechnology Chapter 20 Biotechnology Chapter 20 DNA Cloning DNA Cloning AKA Plasmid-based transformation or molecular cloning First off-let s sum up what happens. A plasmid is taken from a bacteria A gene is inserted into the

More information

Introduction to BIOINFORMATICS

Introduction to BIOINFORMATICS COURSE OF BIOINFORMATICS a.a. 2016-2017 Introduction to BIOINFORMATICS What is Bioinformatics? (I) The sinergy between biology and informatics What is Bioinformatics? (II) From: http://www.bioteach.ubc.ca/bioinfo2010/

More information

ATIP Avenir Program 2018 Young group leader

ATIP Avenir Program 2018 Young group leader ATIP Avenir Program 2018 Young group leader Important dates - October 17th (4 pm) 2017 : opening of the registrations online - November 23 th 2017: deadline for the online submission, the mailing of the

More information

Biotechnology Pathway

Biotechnology Pathway Biotechnology Pathway The Biotechnology Systems (BS) Career Pathway encompasses the study of using data and scientific techniques to solve problems concerning living organisms with an emphasis on applications

More information

Centre for Personalised Medicine in Tübingen - developing tailor-made treatments for patients

Centre for Personalised Medicine in Tübingen - developing tailor-made treatments for patients Powered by Website address: https://www.gesundheitsindustriebw.de/en/article/news/centre-for-personalised-medicine-intuebingen-developing-tailor-made-treatments-for-patients/ Centre for Personalised Medicine

More information

STUDY GUIDE SECTION 13-1 DNA Technology

STUDY GUIDE SECTION 13-1 DNA Technology STUDY GUIDE SECTION 13-1 DNA Technology Name Period Date Multiple Choice-Write the correct letter in the blank. 1. To cut DNA molecules into pieces at specific sequences of nucleotides, genetic engineers

More information

Basic Information. I.1 If your company performs biotechnology research and development, uses a. The Categories of Biotechnology Applications.

Basic Information. I.1 If your company performs biotechnology research and development, uses a. The Categories of Biotechnology Applications. APPENDIX 2 SURVEY QUESTIONNAIRE Part I. Basic Information I.1 If your company performs biotechnology research and development, uses a biotechnology process in manufacturing, or produces research tools,

More information

REGISTRATION DOCUMENT FOR RECOMBINANT DNA RESEARCH

REGISTRATION DOCUMENT FOR RECOMBINANT DNA RESEARCH EHRS Date Received: Reg. Doc. No.: REGISTRATION DOCUMENT FOR RECOMBINANT DNA RESEARCH Principal Investigator: Penn ID#: Position Title: School: Department: Mailing Address: Mail Code: Telephone: FAX: E-mail:

More information

Submission to House of Lords Science and Technology Select Committee Oxford Nanopore Technologies Ltd April 2008

Submission to House of Lords Science and Technology Select Committee Oxford Nanopore Technologies Ltd April 2008 (Previously Oxford NanoLabs) Genomic Medicine Submission to House of Lords Science and Technology Select Committee Oxford Nanopore Technologies Ltd April 2008 Introduction Oxford Nanopore Technologies

More information

"Stratification biomarkers in personalised medicine"

Stratification biomarkers in personalised medicine 1/12 2/12 SUMMARY REPORT "Stratification biomarkers in personalised medicine" Workshop to clarify the scope for stratification biomarkers and to identify bottlenecks in the discovery and the use of such

More information

12/31/16. I. Manipulating DNA (9.1) A. Scientists use several techniques to manipulate DNA. 1. DNA is a very large molecule

12/31/16. I. Manipulating DNA (9.1) A. Scientists use several techniques to manipulate DNA. 1. DNA is a very large molecule I. Manipulating DNA (9.1) A. Scientists use several techniques to manipulate DNA 1. DNA is a very large molecule 3. Led to many biotechnology applications- genetic engineering, DNA fingerprinting, cloning,

More information

The Age of Personalised Medicine Are We Ready?

The Age of Personalised Medicine Are We Ready? CSO s Scientific Meeting, FCI, 7 th March 2017 The Age of Personalised Medicine Are We Ready? Phil Beales Professor of Medical and Molecular Genetics Head of UCL Personalized Medicine Domain UCL Great

More information

Overview of Health Informatics. ITI BMI-Dept

Overview of Health Informatics. ITI BMI-Dept Overview of Health Informatics ITI BMI-Dept Fellowship Week 5 Overview of Health Informatics ITI, BMI-Dept Day 10 7/5/2010 2 Agenda 1-Bioinformatics Definitions 2-System Biology 3-Bioinformatics vs Computational

More information

Chapter 12. DNA Technology. Lectures by Edward J. Zalisko

Chapter 12. DNA Technology. Lectures by Edward J. Zalisko Chapter 12 DNA Technology PowerPoint Lectures for Campbell Essential Biology, Fifth Edition, and Campbell Essential Biology with Physiology, Fourth Edition Eric J. Simon, Jean L. Dickey, and Jane B. Reece

More information

Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms

Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms Genomics Bioinformatics HTS Combinatorial chemistry Protein drugs

More information

Slides are from Level 3 Biology Course Content Day, 7 th November Presenter: Justin O Sullivan

Slides are from Level 3 Biology Course Content Day, 7 th November Presenter: Justin O Sullivan Slides are from Level 3 Biology Course Content Day, 7 th November 2012 Presenter: Justin O Sullivan Teachers are free to use these for teaching purposes with appropriate acknowledgement Personalized genomics

More information

Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development)

Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) Strategies for modern biomarker and drug - Oct 3, 2014 Sequencing the cancer genome

More information

NEW DRUG FORMULATIONS TO BOOST FIGHT AGAINST RESPIRATORY ILLNESSES AND ANTIBIOTIC-RESISTANT SUPERBUGS

NEW DRUG FORMULATIONS TO BOOST FIGHT AGAINST RESPIRATORY ILLNESSES AND ANTIBIOTIC-RESISTANT SUPERBUGS MEDIA RELEASE FOR IMMEDIATE RELEASE 15 September 2014 NEW DRUG FORMULATIONS TO BOOST FIGHT AGAINST RESPIRATORY ILLNESSES AND ANTIBIOTIC-RESISTANT SUPERBUGS A team from A*STAR s Institute of Chemical and

More information

Bioinformatics Institute

Bioinformatics Institute Bioinformatics Institute Opening New Frontiers in Biology Dr Guna Rajagopal, Deputy Director & Professor Santosh Mishra, Executive Director Bioinformatics Institute Introduction At the dawn of the 21st

More information

Precision Medicine in Sepsis

Precision Medicine in Sepsis Precision Medicine in Sepsis Jean-Daniel Chiche, MD PhD jean-daniel.chiche@aphp.fr MICU & Dept Infection, Immunity & Inflammation Hôpital Cochin & Institut Cochin, Paris-F Sepsis 2017: a litany of failed

More information

Introduction to Drug Development

Introduction to Drug Development Introduction to Drug Development Yves Geysels, PhD Head Clinical Research Operations, Belgium Past President of the Associoation of Clinical Research Professionals (ACRP) Board Member of the European Forum

More information

MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE

MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE THE RESEARCH WE DO TODAY WILL DETERMINE THE TYPE OF MEDICAL AND SURGICAL PRACTICE WE CARRY ON AT THE CLINIC

More information

Patenting biotechnological inventions

Patenting biotechnological inventions Patenting biotechnological inventions Izabela Milczarek, PhD, Specialist in Patents Department at Patpol Patpol - European and Polish Patent and Trade Mark Attorneys What is biotechnology? The 20 th century

More information

Antibiotics and alternative strategies to control infections

Antibiotics and alternative strategies to control infections Antibiotics and alternative strategies to control infections http://blog.microbiologics.com/wpcontent/uploads/2015/12/acinetob acter-baumannii-232x300.jpg www.biochemj.org/bj/330/0581/bj3300581.htm ciss.blog.olemiss.edu

More information

Ethical and social issues in Synthetic Biology Patricia Osseweijer

Ethical and social issues in Synthetic Biology Patricia Osseweijer Ethical and social issues in Synthetic Biology Patricia Osseweijer Delft University of Technology & Kluyver Centre for Genomics of Industrial Fermentation BE-Basic The Netherlands National programmes Public

More information

Business and Industry Advisory Committee to the OECD - Comité Consultatif Economique et Industriel Auprès de l OCDE

Business and Industry Advisory Committee to the OECD - Comité Consultatif Economique et Industriel Auprès de l OCDE Business and Industry Advisory Committee to the OECD - Comité Consultatif Economique et Industriel Auprès de l OCDE In Committee BIOTECHNOLOGY: A KEY CONTRIBUTOR TO SUSTAINABLE ECONOMIC GROWTH A Vision

More information

Human Microbiome Project: First Map of the World Within Us. Hsin-Jung Joyce Wu "Microbiota and man: the story about us

Human Microbiome Project: First Map of the World Within Us. Hsin-Jung Joyce Wu Microbiota and man: the story about us Human Microbiome Project: First Map of the World Within Us Immune disorders: The new epidemic Gut microbiota: health and disease Disease Health Human Microbiome Project: The concept of superorganism :

More information

REGISTRATION DOCUMENT FOR RECOMBINANT & SYNTHETIC DNA RESEARCH

REGISTRATION DOCUMENT FOR RECOMBINANT & SYNTHETIC DNA RESEARCH IBC Date Received: Reg. Doc. No.: REGISTRATION DOCUMENT FOR RECOMBINANT & SYNTHETIC DNA RESEARCH Principal Investigator: --------------------------------------- Position Title: -------------- Department:

More information

ICH Topic E15 Definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories.

ICH Topic E15 Definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories. European Medicines Agency November 2007 EMEA/CHMP/ICH/437986/2006 ICH Topic E15 Definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories Step 5

More information